Konig SA, Siemes H, Blaker F, Boenigk E, Gross-Selbeck G, Hanefeld F, Haas N, Kohler B, Koelfen W, Korinthenberg R: Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities
When mitochondrial function is impaired, patients often experience fatigue, brain fog, exercise intolerance, poor recovery, and slower metabolism
(PubMed) Carr AC, Maggini S
For example, animal studies suggest that BPC-157 promotes neovascularization and speeds up the formation of new blood vessels that may be at risk for faster disease progression in cancer patients
How many sessions are required to see results
This is standard step therapy, and most endocrinologists are familiar with the documentation requirements